stiff-person syndrome
stiff-person syndrome
Explore linked clinical trials. Standard reference: MONDO:00084919 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VYVGART (Hytrulo) in Patients With Stiff Person Syndrome (SPS) | autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, immune system disorder, nervous system disorder, neuromuscular disease, spinal cord disorder, stiff-person syndrome | Recruiting | Phase 2 / Phase 3 | 2026-10-06 | NCT07860021 | |
| A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome | autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, immune system disorder, nervous system disorder, neuromuscular disease, spinal cord disorder, stiff-person syndrome | Not yet recruiting | Phase 3 | 2026-09-14 | NCT07552987 | |
| A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, central nervous system disorder, chronic progressive multiple sclerosis, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromuscular disease, neuromyelitis optica, optic nerve disorder, optic neuritis, spinal cord disorder, stiff-person syndrome | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-09 | NCT07804004 | |
| Biomarkers in Autoimmune Disease of Nervous System | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Guillain-Barre syndrome, Leukoencephalopathies, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, acquired idiopathic inflammatory myopathy, acute disseminated encephalomyelitis, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, brain disorder, central nervous system disorder, chronic inflammatory demyelinating polyradiculoneuropathy, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myositis disease, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy, spinal cord disorder, stiff-person syndrome | Recruiting | Not stated | 2026-07-29 | NCT06502015 | |
| A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, acquired idiopathic inflammatory myopathy, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, autoimmune disorder of the nervous system, cardiovascular disorder, central nervous system disorder, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nephritis, nervous system disorder, neuromuscular disease, skin disorder, skin vascular disease, spinal cord disorder, stiff-person syndrome, systemic lupus erythematosus, systemic sclerosis, urinary system disorder, vascular disorder, vasculitis | Enrolling by invitation | Phase 1 | 2026-03-19 | NCT06375993 | |
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Dyskinesias, Lambert-Eaton myasthenic syndrome, Myoclonus, Neoplasms by Site, Neurologic Manifestations, Ocular Motility Disorders, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rasmussen subacute encephalitis, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebellar degeneration, cerebrovascular disorder, chronic inflammatory demyelinating polyradiculoneuropathy, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, opsoclonus-myoclonus syndrome, optic nerve disorder, optic neuritis, paraneoplastic syndrome, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy, spinal cord disorder, stiff-person syndrome, vascular disorder, vasculitis | Active, not recruiting | Phase 2 | 2026-02-27 | NCT00716066 | |
| A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 | CNS demyelinating autoimmune disease, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, connective tissue disorder, demyelinating disease, dermatomyositis, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, spinal cord disorder, stiff-person syndrome, systemic lupus erythematosus, systemic sclerosis, urinary system disorder | Recruiting | Not stated | 2026-02-11 | NCT07403188 | |
| A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy | CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, central nervous system disorder, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, nervous system disorder, neuromuscular disease, neuromyelitis optica, optic nerve disorder, optic neuritis, spinal cord disorder, stiff-person syndrome | Not yet recruiting | Phase 1 | 2026-01-15 | NCT07341828 | |
| Efgartigimod for Stiff Person Syndrome (ESPS) | autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, immune system disorder, nervous system disorder, neuromuscular disease, spinal cord disorder, stiff-person syndrome | Not yet recruiting | Phase 2 | 2025-04-11 | NCT06528392 |